Cancer Conferences 2020 | Top Oncology Conferences | Congress | Meetings | Events | Workshops | Europe | Global

Recommended Global Oncology & Cancer Conferences

Europe & UK

Breast Cancer 2020, Germany Cancer Treatment 2020, Italy Cancer Science 2020, Italy Cell Signaling 2020, UK

Asia Pacific & Middle East

cancer summit-2019, Japan Cancer Research 2020, Japan global cancer summit 2020, Japan Women Oncology 2020, Japan

Canada

Entrepreneurship Education 2019, USA MCS 2020, Canada Global Nursing Education 2020, USA

World Cancer-2020

About Conference

It is a great delight and prestige to extend to you a warm invitation to attend the 5th World Congress on Cancer and Diagnostics, to be held June 15 – 16, 2020 in Berlin, Germany. We cordially welcome all the prominent researchers, students and delegates to take part in this forthcoming conference to witness precious scientific discussions and contribute to the future reformation in the field of Cancer. World Cancer -2020 will be sorted out around the theme “Enlightening The Advancements And Exploring The New Horizons In Cancer"

5th World Congress on Cancer and Diagnostics directs towards the main issues as well as future strategies of Cancer. This is going to be the largest and most promising international conference bridging the gaps between the intellectuals from across the globe to enlighten their research and findings at 5th World Congress on Cancer and Diagnostics where the program includes Clinical Oncologist and whole medical team involved in cancer patient care, researchers, professional, early career individuals and patient advocates. To investigate the new thoughts and ideas on worldwide scale and the points incorporate lung malignant growth, bosom disease, bone malignant growth, leukemia, blood cancer, cervical disease, colon-rectum disease, pediatric disease, careful malignant growth, thyroid malignant growth, Prostate malignant growth.

In 2016, an expected 1,685,210 new instances of malignant growth will be analyzed in the United States and 595,690 individuals will kick the bucket from the illness. The most widely recognized malignant growths in 2016 are anticipated to be bosom disease, lung and bronchus cancer growth, prostate cancer, colon and rectum cancer, bladder cancer.

The quantity of new instances of malignancy (disease occurrence) is 454.8 per 100,000 people for each year (in light of 2008-2012 cases). Cancer mortality is higher among men than ladies (207.9 per 100,000 men and 145.4 per 100,000 ladies). It is most noteworthy in African American men (261.5 per 100,000) and least in Asian/Pacific Islander ladies (91.2 per 100,000). (In view of 20012-2014 passings.)

The quantity of individuals living past a disease conclusion achieved about 14.5 million of every 2014 and is required to ascend to just about 19 million by 2024.

Sessions/Tracks

Track1: Cancer Biomarker

A cancer biomarker indicate to a substance or process that symbolize the presence of cancer in the body. A biomarker might be a molecule secreted by a tumour or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be prefer for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to forsee how intensely your cancer will grow, and are therefore useful for determining your prognosis, the most vital use of biomarkers today is to diagnose which therapies a patient’s cancer may or may not respond to.

Molecular Cancer Biomarkers

Tumor Suppressors Biomarkers

Predictive & Prognostic Biomarkers

Companion Biomarker

Related Cancer Conferences:

Cancer Genetics Course 2018, January 29-February 01, 2018, London, United Kingdom; Targeted Anticancer Therapies, March 5-7, 2018, Paris, France; Keystone Symposia: T Cell Dysfunction, Cancer Infection, January 16-20, 2018, Breckenridge, USA; Practical Recommendations in Immuno and Molecular Oncology Meeting, January 31-February 3, 2018, Maui, USA; 4^th EACR conference on A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments, February 1-3, 2018, Amsterdam, Netherlands; 10^th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer, February 11-13, 2018; 3^rd Edition of International Conference on Colorectal Cancer, October 11-12, 2018, Zurich, Switzerland; 26^th Annual Congress on Cancer Science and Therapy, October 03-04, 2018 LA, USA; 36^th World Cancer Conference, October 11-13, 2018, Zurich, Switzerland; International Conference on Cancer Research & Pharmacology, March 26-27, 2018, Edinburgh, Scotland; 21^st Global Experts meeting on Oncology & Cancer Case Reports, February 26-28, 2018, Paris, France.

Track 2: Cancer Immunology & Immunotherapy

Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. Cancer immunotherapy also known as Immuno-oncology is the use of the immune system to treat cancer. Immunotherapies can be classified as active, passive or hybrid (active and passive). The immune response, including the detection of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.

Host-Tumor Relation

Cancer Immunosurveillance and Immunoediting

Clinical Cancer immunology

Cancer Antigens & Vaccines

Cellular Immunotherapy

Antibody Therapy

Cytokine Therapy

Combination & Combinatorial Ablation and Immunotherapies

Related Cancer Conferences:

Track 3: Cancer: Lifestyle and Nutrition

Many factors impact the development of cancer. Over the last 25 years, science has displayed that diet, , body weight and physical activity —especially being overweight or obese—are leading risk factors for obtaining certain types of cancer. Around a third of the most common cancers could be blocked through lifestyle changes. The main behavioral and environmental risk factors for cancer death in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to confront cancer may be helped by succeeding a healthy diet, staying physically active, and escaping excess body fat. Cancer and cancer treatments can also alter your body's ability to tolerate certain foods and use nutrients.

Related Cancer Conferences:

Track 4: Oncology Nursing and Care

Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist, head, and scientist. Oncology and malignant growth nursing stretches out to all mind conveyance settings where customers encountering or in danger for creating disease get social insurance, training, and directing for malignancy counteractive action, screening and recognition. It additionally includes suitable screenings and other protection rehearses, indication the executives, care to hold however much ordinary working as could be expected, and steady endless supply of life. An oncology nurture is a nursing proficient who has some expertise in thinking about individuals with malignant growth. Oncology nurture frequently fill in as your first line of correspondence, and help arrange the numerous parts of your consideration all through malignant growth treatment. Nursing Management is a vital section of the nursing training. The nursing experts in radiation oncology field will be very demandable. Oncology nursing experts generally gives the palliative consideration for patients and solaces them. World Cancer - 2019 will make another transformation in malignancy science and disease nursing field.

Related Cancer Conferences:

Track 5: Cancer Screening

Not at all like analytic endeavors provoked by side effects and therapeutic signs, cancer screening includes endeavors to recognize disease after it has framed, however before any observable manifestations show up. This may include physical examination, blood or urine tests or therapeutic imaging.

Cancer growth screening isn't accessible for some kinds of cancers. Notwithstanding when tests are accessible, they may not be prescribed for everybody. All inclusive screening or mass screening includes screening everybody. Particular screening distinguishes individuals who are at higher hazard, for example, individuals with a family ancestry. A few variables are considered to decide if the advantages of screening exceed the dangers and the expenses of screening. These elements include:

Conceivable damages from the screening test: for instance, X-Ray pictures include presentation to possibly hurtful ionizing radiationThe probability of the test accurately recognizing cancer growth

The probability that disease is available: Screening isn't regularly valuable for uncommon cancer growths.

Screening mammography

Prostate Cancer Screening

Pancreatic Cancer Screening

Oral Cancer Screening

Lung Cancer Screening

Colorectal Cancer Screening

Cervical Cancer Screening

Breast Cancer Screening

Whole Body Imaging

Diagnostic Testing

Molecular Oncology

Innovation in Genetic Testing

Pre Symptomatic Gene Testing

NGS Testing

Related Cancer Conferences:

Track 6: Targeted Cancer Therapies

Targeted therapy is a exclusive type of chemotherapy that exploits differences between normal cells and tumor cells. It's periodically utilized alone, however constantly other disease medicines are utilized with targeted therapy.

As the name suggests, targeted therapies hamper with particular proteins engaged with tumorigenesis. Instead of applying expansive base growth medications, concentrating on particular atomic changes which are one of a kind to a specific disease, directed tumor treatments might be all the more therapeutically gainful for some malignancies, including lung, colorectal, breast, lymphoma and leukaemia.

Targeted drugs can work to:

Block or turn off chemical signals that tell the cancer cell to grow and divide

Change proteins within the cancer cells so the cells die

Stop making new blood vessels to feed the cancer cells

Trigger your immune system to kill the cancer cells

Carry toxins to the cancer cells to kill them, but not normal cells

Monoclonal antibodies

Small molecule drugs

Targeted therapy for breast cancer

Targeted therapy for Colorectal Cancer

Targeted therapy for Lung Cancer

Targeted therapy for Melanoma

Challenges of targeted therapies

Related Cancer Conferences:

Track 7: Cancer Diagnosis & Cancer diagnostics

Electromagnetic radiation Magnetic reverberation imaging is a procedure of making X-Rays that produces solid attractive fields just as radio waves to get point by point pictures of the inside body site. Biopsy is procedure of therapeutic test so as to discover the presence of cancer in our body. For the most part this test will endorse by an oncologist, interventional radiologist, or an interventional cardiologist that includes test of cells or tissues for examination. A total blood check (CBC) gives noteworthy information about the include and sorts of cells in the blood, particularly white platelets camera.gif, red platelets camera.gif, and platelets. Disease arranging is the technique for controlling malignant growth development to certain degree by spreading. The TNM Classification of Malignant Tumors is the arrangement of Cancer Staging that gives codes to represent an individual's disease organize, when this infers with a strong tumor. Analyzing Image Studies

Bone Marrow Aspiration

Genetic Analysis

Endoscopy Analysis

Sputum Analysis

Pap Test Analysis

Related Cancer Conferences:

Track 8: Oncology Saviours

Malignant growth is to some degree like a common disease. For the most part, this class must incorporate just individuals who are noticeable for being made due by malignant growth, especially, the individuals who have readily taken an interest in open activism of issues related to disease. As we need to regard individuals' eudemonia. Data about individuals' eudemonia, including their situation as a malignancy survivor, should dependably be featured by high caliber, non-independently published solid source. By observing class individuals causes malignancy. For individuals who have terminated from cancer growth or its treatment.

Breast Cancer Saviour

Colorectal Cancer Saviour

Kidney Cancer Saviour

Liver Cancer Saviour

Lung Cancer Saviour

Paediatrics Cancer Saviour

Testicular Cancer Saviour

Related Cancer Conferences:

Track 9: Pharmaceutical Oncology

A multidisciplinary way to deal with redesign has been connected in a variety of settings in clinical oncology, especially among patients with stomach and colorectal malignancy. Multidisciplinary care fuses different orders that current assets to improve treatment designs and builds up patients of life. In spite of the fact that the commitment of clinical drug specialists as a major aspect of the multidisciplinary group in the oncology division. Malignant growth Drugs were connected so as to treat the disease and lessening indications of the disease, and reactions, for example, queasiness. Specialists would treat the malignant growth patients with at least two medications that were utilized in chemotherapy and once in a while with different meds, for example, steroids. Hostile to malignancy drugs kill disease cells by anticipating development or impeding augmentation at certain point in their life cycles. Immunizations were medications that builds up the invulnerable framework's normal capacity to protect the body from "remote intruders," that for the most part shapes an irresistible operators that may cause innate infection. HPV immunization and Hepatitis B antibody were disease counteractive action antibodies upheld by the U.S. Nourishment and Drug Administration (FDA). Disease treatment immunizations were likewise considered restorative antibodies that expansion the capacity of insusceptible framework to recognize and abrogate the antigens.

Theoretical Medicines

Anti-Metabolite Drugs

Alkylating Agents

Microtubule Inhibitor

Steroid Hormones

Miscellaneous Agents

Natural Agents

HMT Inhibitors

Biological Respond Modifier

Related Cancer Conferences:

Track 10: Cancer Science & Cancer Therapies

Cancer Therapy is a most recent method for treating the malignant growth that utilize drugs or other material substances to distinguish and attack on disease cells, for the most part while little harm is going on to typical cells. Directed treatment is delivering the development of numerous disease treatment regimens. Molecularly focused on treatment is one among the key modalities of therapeutic treatment for disease. The Drugs applied by explicit focusing on qualities. These qualities are started in disease cells or in cells connected to malignant growth development, for example, vein cells. As game plans of sub-atomic prescription, directed treatment obstructs the development of malignancy cells by interloping with explicit focused on particles required for carcinogenesis and tumor development, rather than just meddling with all quickly separating cells.

Health Economics in Cancer Treatment

Implication of Cancer Therapy

Innovation in Cancer Treatment

Immunotherapy

Surgical Therapy

Targeted Therapy

Radio Therapy

Related Cancer Conferences:

Track 11: Cancer Vaccination

It is the arrangement of antigenic framework material is utilized to excite an individual resistant framework to keep the pathogens. Immunizations are the preventive proportions of irresistible infections. The Influence of the antibodies are been advanced around the world. This is one of the techniques for avoiding irresistible ailments all the more viably. By utilizing, immunization technique we have counteracted numerous ailments, for example, smallpox. The antibody of little pox was found by the Louis field. Through this lead of immunization we have annihilated small pox by 1979. In disease the tumor antigen drove a way towards antigen explicit immunotherapy of malignant growth. Today hostile to – tumor inoculation haven't achieved its guarantee goal. This happens due to the disappointment incorporates tumor invulnerable getaway system, restrictions in accessibility of tumor explicit antigens in the goal immunological setting.

Hepatitis B Vaccine

Pneumococcal Vaccine

Imnunopotentiators

Vaccination

Action of Cancer Vaccines

Related Cancer Conferences:

Track 12: Cancer Prevention

Cancer Prevention is an achievement hauls towards lower possibility of getting disease. In 2017, 1.6 million individuals were determined to have malignancy in the United States. The physical issues as well as the passionate misery was brought about by malignant growth, the costly expenses of consideration are additionally a commitment to patients, their families, and to people in general. With the anticipation disease, the quantity of new instances of malignant growth can be diminished. Hopefully, this will direct the heap of malignant growth and disease passing number will diminish. The danger of malignant growth can be consolidated through eating regimen and other way of life change. Tobacco is absolutely connected with malignancy, so blocking tobacco can lessen the peril of lung disease. Lessening the dimension of liquor can diminish the peril of neck throat and esophageal cancer. Influencing uncovered skin by spreading sunscreen creams so as to lessen the danger of skin disease. Malignancy can be taken care of by numerous medications like chemotherapy, radiation treatment, hormonal treatment, target treatment, and palliative consideration.

Psychological Aspects

Hereditary Aspects

Food Habitats

Immunized Aspects

Chronic Inflammation

Related Cancer Conferences:

Track 13: Cancer Bioinformatics

It is another integrated region including organic, measurable and computational sciences. Now a day’s bioinformatics modification is for the most part utilized for the special growth investigation. Ribosomal S6 protein kinase 4 (RSK4) is a fundamental novel tumor silencer that binds breast cancer cell development and commence senescence. Utilizing pair proclivity cleaning, we got protein buildings that correlate with RSK4 or RSK4m. Mass range examination was performed to differentiate the acquired protein edifices, and bioinformatics investigation was performed.

Cancer Bioinformatics

Bioinformatics Gene

Bioinformatics Drug

Translational Bioinformatics

Biology Bioinformatics

Related Cancer Conferences:

Track 14: Hormonal Therapy

In women, the body of the women is comprised of ovaries. Estrogen creates hormone receptor that prompts the positive bosom malignancy development. Subsequently, gathering the measure of estrogen can abbreviate the danger of an early life-arrange. These prescriptions are utilized to diminish the development of cutting edge organize. As there are following kinds of hormonal treatment prescription, for example, aromatase inhibitors, particular estrogen receptor modulators, just as estrogen receptor down controllers. In few cases, the medical procedure will goes about as a noteworthy job, for example, the ovaries just as the fallopian tubes reallocated by the careful technique so as to treat the hormone-receptor-positive bosom malignant growth. Surrender of ovaries is done briefly by drug. It is important to realize that hormonal treatment isn't hormone substitution treatment (HRT). HRT does not used to treat bosom malignant growth. It used to treat the troublesome menopausal reactions in ladies, for example, hot flashes and mood swings.

SERMs

LHRH Agonists

Oophorectomy

Aromatase Inhibitors

Role of Anti Androgens

Biodentical

Side Effects of Hormonal Therapy

Related Cancer Conferences:

Track 15: Cancer Biology

Cancer cells have the ability to partition in a wild way. Malignant growth cells disregard flags that will be dynamic in ceasing the cell division, apoptosis and cell shedding. In a malignant growth cell, a large portion of the qualities transform into a blemished one. Harmful tumors can spread into, or attack, close-by tissues so they are the reason for danger. By the movement of these tumors, some disease cells can be divided and travel to different parts in the body through the plasma or the lymphatic framework and structures another tumor cell far from the first tumor which is called metastasis. Malignancy pathogenesis manages the atomic, biochemical, and cell-based methodologies are incorporated into disease cell science to more readily get it. Disease Genetics manages the malignant growth development because of hereditary changes, if the progressions are available in germ cells it very well may be acquired from guardians to off-springs. Tumor Immunology assumes an imperative job in choice of new methodologies for malignancy therapeutics. Malignancy Science Conferences articulate the advancements in the disease science field.

Cancer Pathogenesis

Cancer Tumors

Molecular Oncology

Tumor Immunology

Cancer Genetics

Cancer Pharmacology

Related Cancer Conferences:

Track 16: Cancer Pharmacology

Pharmacology deals with action of drug in the body. Cancer Pharmacology deals with the drugs used in cancer treatment, their mechanism of action, their side effects and their mode of elimination. Combination of Drugs and their efficacy has been a major choice of research interest.

Cancer Drugs

Anti-cancer drugs mechanism of action

Cancer Drugs absorption and Distribution

Cancer Drugs Metabolism

Side Effects of Synthetic Drugs in Cancer Treatment

Related Cancer Conferences:

Market Analysis

Market Analysis:

Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. If the spread is not controlled it can result in death. Although the reason for many cancers, particularly those that occur during childhood, remains unknown, established cancer cause lifestyle (external) factors such as tobacco use and excess body weight and not modified (internal) factors such as inherited genetic mutations, hormones and immune conditions. These factors may act simultaneously or in sequence to initiate and/or promote cancer growth. Ten or more years often pass to expose to external factors and detectable cancers. Not all tumors are cancerous which benign tumors do not extend to other body parts. Cancer also called as a malignant neoplasm or malignant tumor.

International Conference on Cancer and Diagnostics will be the best platform for oncologists, radiologists, pathologists, Immunologists, researchers working in this field to connect and exchange ideas.

Scope and Significance:

Cancer in Rome is becoming a serious health problem. It is the leading cause of mortality in Rome. The annual years of healthy life lost per 100,000 people from cancer in Rome has increased by 57.0% since 1990, an average of 2.5% a year.

International Congress on Cancer and Diagnostics will be the best platform for all the radiologists, oncologists, explore researchers, undergraduates who are working in this field to trade their insight identified with Cancer and oncology. This worldwide meeting is to explore above the frontiers in research in tumor like Lung Cancer, Liver Cancer, Breast Cancer, Kidney Cancer, and Cancer in grown-ups and disease in youngsters. The rate of annual years of healthy life lost because of cancer has changed over time for men and women of specific age groups in Rome. The Importance of International Conference on Cancer and Diagnostics is to redesign, clinically critical gathering of Oncologists and people concerning the confirmation and flow advances in finding and treatment in the field of Cancer Research.

Market Analysis Report:

Worldwide disease drugs advertise represented $78,238.9 million out of 2016. The malignant growth drugs showcase is driven by the developing pervasiveness of different sorts of disease, expanding request of organic and focused on medication treatments, ceaseless patent expiry of key malignancy drugs and the rising effect of Biosimilars. In any case, the mind-boggling expense of medication advancement, the danger of disappointment and the antagonistic impacts of disease tranquilize treatment, especially chemotherapy, blocks the market development. Created countries have executed severe guidelines for the structure and advancement of disease drugs. USFDA and European Union have embraced noteworthy activities to fuel the development of the malignant growth drugs showcase by giving pre-advertise endorsement to potential medications under clinical improvement. Asia-Pacific and LAMEA are promising districts for directing clinical preliminaries due an extensive populace base and the minimal effort of clinical preliminaries when contrasted with North America and Europe. In any case, headway of malignancy sedate research attributable to natural/directed treatments and customized medications hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating disease drugs.

Why Berlin, Germany?

Germany is a grouping of timeless tradition and leading-edge cool, wrapped up in a package of spectacular landscapes, architectural masterpieces, idyllic half-timbered villages and lively metropolises and fairy-tale palaces.

Berlin has grown-up evermore, but it hasn't capitulated its transmissible energy and indie spirit. Berlin spoils visitors with quirky and classic diversions. There’s haute cuisine in an ex-brewery, world-class art in a WWII bunker, all-night parties in power stations and the chance to chill in a river barge-turned-swimming pool. Buildings marking milestones in history – the Reichstag, the Brandenburg Gate and Checkpoint Charlie among them – rub shoulders with 175 museums, including such top acts as the Pergamonmuseum, with its monumental antiquities, and the Hamburger Bahnhof, that boasts bold contemporary art. Sweeping views unfold from the TV Tower and the Reichstag Dome, while down below, tourist boats glide past the Nikolaiviertel, the site of Berlin’s medieval beginnings.

The history of science in Berlin is full of the names of famous scholars like Humboldt, Einstein, Virchow, Koch, Meitner and Planck. Major national research organizations such as Fraunhofer, the Helmholtz Association and the Leibniz Association are represented in Berlin by various institutions and research sites. Germany's major concentration of universities and colleges is in Berlin, a leading center of science, academics, and research, not least thanks to its 39 institutions of higher education. Germany’s national research organizations are represented in Berlin with several institutes, as are eight federal ministry research facilities. Together with Berlin's universities, nearly 100 research institutions in the city form an important basis for the region's economic development.

40 Nobel Prize winners are affiliated to the Berlin-based universities. Medicine, medical technology, biotechnology, information and communications technology, optical technology, material sciences, transportation and environmental technologies, and the humanities and social sciences are the principal focus of research being done in Berlin. Berlin’s research projects are part of global networks and are familiar worldwide.

Berlin is the most desirable tourist destination, and hence the perfect place to hold such event.

Why to attend

Emerging Materials Congress 2020 affords outstanding opportunity to meet and make new contacts that associates you with delegates in the field of Nanotechnology, Materials Science and Engineering, by providing break-out space with tea and lunch for delegates between sessions with helpful networking time to uncover new ideas. The important subjects are lectured by the globally recognized key note speakers thus discussing on the emerging technologies and advancements in the sphere of Materials Science and Nanotechnology.

Target Audience:

Oncologists

Radiologists

Immunologists

Clinical Researchers

Nursing

Malignancy Researchers

Researchers

Youthful Researchers

Undergraduates

Biomarker Associations and Societies

Business Entrepreneurs

Preparing Institutes

Programming creating organizations

Information Management Companies

Pharmaceutical Companies

Diagnostics Companies

Conference Highlights:

Cancer Biomarkers

Cancer Immunology & Immunotherapy

Cancer: Lifestyle and Nutrition

Oncology Nursing and Care

Cancer Screening

Targeted Cancer Therapies

Cancer Diagnosis & Cancer diagnostics

Pharmaceutical Oncology

Oncology Saviors

Cancer Science & Cancer Therapies

Cancer Vaccination

Cancer Prevention

Cancer Bioinformatics

Hormonal Therapy

Cancer Biology

Cancer Pharmacology

Major Cancer Associations across the Globe:

American Association for Cancer Research
Virginia Cancer Institute
American Brain Tumor Association
American Society of Pediatric Hematology/Oncology
Association of Cancer Physicians
American Childhood Cancer Organization
American Society of Clinical Oncology
Australasian Lung Cancer Trials Group
International Cancer Research Partnership (ICRP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
International Agency for Research on Cancer (IARC)
Cancer Society of New Zealand
Irish Cancer Society
Australian Cervical Cancer Foundation
Medical Centre Cologne
Cancer Research UK
Australian Prostate Cancer Research
Peter McCollum Cancer Centre
The European Cancer Organization (ECCO)
German Cancer Research Centre

Major Medical Universities:

Worldwide

Harvard University
University of Minnesota
Mayo Medical School
Pittsburgh School of Medicine
Yale University
University of Cambridge
University of Oxford Stanford University
Yale University
Emory University
John Hopkins University
Kings College London
Feinberg School of Medicine
University of Wisconsin
UNC School of Medicine
Karolinska University
The University of Tokyo
National University of Singapore (NUS)
Kyoto University
University of Hong Kong (HKU)
Peking University
Seoul National University (SNU)
National Taiwan University (NTU)
Osaka University
Tsinghua University0
The Chinese University of Hong Kong (CUHK)
Fudan University
The Hong Kong University of Science and Technology (HKUST)
Taipei Medical University
Mahidol University
KAIST - Korea Advanced Institute of Science and Technology
Yonsei University
Shanghai Jiao Tong University
Nanyang Technological University (NTU)
Chulalongkorn University
Tohoku University
Tokyo Medical and Dental University
Kyushu University
Nagoya University
Hokkaido University
Sungkyunkwan University
University of Science and Technology of China
Pohang University of Science and Technology (POSTECH)
Korea University
Universiti Malaya (UM)
Zhejiang University
Keio University
Indian Institute of Science
University of Tsukuba
University of Delhi

Past Conference Report

Cancer Summit 2018

World Cancer Summit 2018

Cancer Summit 2018 meeting has given us the prospect to bring the event once again. Conference series llc Ltd facilitated the "World Cancer Summit 2018" amid July 02-03, 2018, Bangkok, Thailand.

The meeting was centered on finding out about Oncologists with the topic "Exploring the possibilities in closing the era of Cancer". The gathering chiefly coordinates towards tending to primary issues like Prevention, Diagnosis, and Treatment infections of the Organ-related Cancers and its inventive methods. Cancer Summit 2018 is a champion among the most reviving Cancer Conferences dealt with by Conference series llc Ltd.

This Cancer Summit 2018 was discussed on procedures and strategies related to organization, quality difference in Cancer and to explore the new contemplations and thoughts on overall scale and the focuses join lung tumor, bosom danger, bone development, cervical development, colon-rectum infection, prostate tumor, thyroid tumor. The gathering was set out with an opening function took after by Sessions and took after by arrangement of addresses conveyed by both Honorable Guests and individuals from the Keynote discussion. The adepts who declared the topic with their impeccable talk were:

Shashikant Limbachiya, Narayana Multispecialty Hospital, India
Dagmara Poprawski, Country Health South Australia Local Health Network, Australia
Jang Mi Han, Sun Moon University South Korea
Haet Nim Lim, Sun Moon University South Korea
Kuo-Wang Tsai, Sun Moon University South Korea
Dariusz Borys, Loyola University Chicago, USA
Lyudmila Severyanova, Kursk State Medical University, Russian Federation
Anshoo Agarwal, Northern Border University, Kingdom of Saudi Arabia
Nor Ashikin Mohamed Noor Khan, Universiti Teknologi MARA, Malaysia
SIN Chun Fung, University of Hong Kong, Hong Kong

Conference Series llc Ltd offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference Series llc Ltd and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer Summit 2018, Conference Series llc Ltd would like to announce the commencement of the “5th International Congress on Cancer and Diagnostics” to be held during June 15-16, 2020 Berlin, Germany. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology and Cancer Research.

For More details: http://worldcancer.cancersummit.org/

Let us meet again @ World Cancer-2020

Past Reports Gallery